We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
India's top drug regulator.
- Authors
Jayaraman, Killugudi
- Abstract
The article focuses on Gyanendra Nath Singh, Drugs Controller General of India (DCGI), who was tasked to watch over drug regulatory agency in India. Topics discussed include Central Drugs Standard Control Organization (CDSCO), the major body for pharmaceuticals and medical devices in India, U.S. Food and Drug Administration's (FDA) banning of products made by drugmaker Ranbaxy Laboratories Ltd.'s plant in Toansa, India, and compliance with good manufacturing practice (GMP).
- Subjects
INDIA; SINGH, Gyanendra Nath; UNITED States. Food &; Drug Administration; INDEPENDENT regulatory commissions; CENTRAL Drugs Standard Control Organization; PHARMACEUTICAL industry; CURRENT good manufacturing practices; RANBAXY Laboratories Ltd.
- Publication
Nature Medicine, 2014, Vol 20, Issue 8, p802
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm0814-802